No abstract available.
Cluster Headache* ; Erythema Multiforme* ; Erythema* ; Herpes Simplex

No abstract available.
Aneurysm* ; Carotid Artery, Internal* ; Cluster Headache ; Headache* ; Intracranial Aneurysm

BACKGROUND: Cluster headache is a primary headache disorder characterized by periodic episodes of intense headache accompanied by autonomic symptoms. We report an unusual clinical presentation of cluster headache that was preceded by myoclonus and accompanied by hemiparesis. CASE REPORT: A 26-year-old man visited hospital due to recurrent jerky movements on the left side of his face and neck area lasting 3 days. These jerky movements had disappeared spontaneously without specific treatment. On the 10th day after onset of the jerky movements, the patient developed a series of unilateral severe headaches that were accompanied by autonomic symptoms lasting 1-2 hours. According to the second edition of The International Classification of Headache Disorders, he was diagnosed as having cluster headache. Two of the 16 severe headache attacks this patient suffered were accompanied by dysarthria and hemiparesis. Electroencephalography performed during hemiparesis revealed diffuse lateralized slow activity on the ipsilateral hemisphere of the headache side. The headache and accompanying hemiparesis disappeared after medical treatment for cluster headache. CONCLUSIONS: We describe a case of cluster headache accompanied by hemiparesis, which was preceded by myoclonus. We also outline the possible mechanisms underlying this case.
Adult ; Cluster Headache ; Dysarthria ; Electroencephalography ; Headache ; Headache Disorders ; Headache Disorders, Primary ; Humans ; Myoclonus ; Neck ; Paresis

Cluster headache (CH) is considered a primary headache syndrome. However, symptomatic cases that resemble CH have also been reported. A patient with cerebral venous thrombosis presented with ipsilateral frontal pain accompanied by ophthalmoparesis, nasal congestion, and lacrimation. The patient's headache showed a dramatic response to oxygen. He experienced no further cluster-like headaches after treatment with an anticoagulant. This case suggests the possible role of venous stasis of the cavernous sinus in cluster-like headache.
Cavernous Sinus ; Cluster Headache ; Estrogens, Conjugated (USP) ; Headache Disorders ; Headache* ; Humans ; Ophthalmoplegia ; Oxygen ; Venous Thrombosis*

No abstract available.
Cluster Headache ; Trigeminal Autonomic Cephalalgias ; Trigeminal Nerve Diseases

A cluster headache is characterized by the occurrence of strictly unilateral and periocular pain with no side shift and ipsilateral oculofacial autonomic symptoms such as conjunctival injection, lacrimation, rhinorrhea and miosis. Cluster headache involves the activation of parasympathetic nerve structures located within the sphenopalatine ganglion, and blockade of the sphenopalatine ganglion has been shown to be effective at the treatment of cluster headaches that are resistant to conventional therapy. Herein, we describe a case of a 50-year-old male with a cluster headache that could not be controlled by conventional treatments who showed improvement after being treated with sphenopalatine ganglion pulsed radiofrequency.
Cluster Headache* ; Ganglion Cysts* ; Humans ; Male ; Middle Aged ; Miosis

OBJECTIVE: To master the clinical manifestations of rhinogenic headache and improve the diagnostic ability of chronic rhinosinusitis accompanied by primary headache. METHOD: The clinical manifestations, the diagnostic process, and the treatment of 1 patient with headache were analyzed, and also the related articles were studied. RESULT: Rhinogenic headache and primary headache had different clinical features and different treatment. In clinical work misdiagnosis were easily made if not being carefully analyzed. CONCLUSION Diagnosis of rhinogenic headache do need strong clinical evidence, but the differential diagnosis of other headache should be made.
Cluster Headache ; complications ; Humans ; Male ; Middle Aged ; Sinusitis ; complications

BACKGROUND AND PURPOSE: Cluster headache (CH) is frequently either not diagnosed or the diagnosis is delayed. We addressed this issue by developing the self-administered Cluster Headache Screening Questionnaire (CHSQ). METHODS: Experts selected items from the diagnostic criteria of CH and the characteristics of migraine. The questionnaire was administered to first-visit headache patients at nine headache clinics. The finally developed CHSQ included items based on the differences in responses between CH and non-CH patients, and the accuracy and reliability of the scoring model were assessed. RESULTS: Forty-two patients with CH, 207 migraineurs, 73 with tension-type headache, and 18 with primary stabbing headache were enrolled. The CHSQ item were scored as follows: 3 points for ipsilateral eye symptoms, agitation, and duration; 2 points for clustering patterns; and 1 point for the male sex, unilateral pain, disability, ipsilateral nasal symptoms, and frequency. The total score of the CHSQ ranged from 0 to 16. The mean score was higher in patients with CH than in non-CH patients (12.9 vs. 3.4, p < 0.001). At a cutoff score of >8 points, the CHSQ had a sensitivity, specificity, positive predictive value, and negative predictive value of 95.2%, 96%, 76.9%, and 99.3%, respectively. CONCLUSIONS: The CHSQ is a reliable screening tool for the rapid identification of CH.
Cluster Headache* ; Diagnosis ; Dihydroergotamine ; Headache ; Headache Disorders, Primary ; Humans ; Male ; Mass Screening* ; Migraine Disorders ; Prevalence ; Sensitivity and Specificity ; Tension-Type Headache

BACKGROUND: The International Classification of Headache Disorders, an essential tool in the diagnosis of headache disorders, has been revised as its 3rd edition, beta (ICHD-IIIbeta). The clinical application in practice is needed to test the feasibility and usefulness of the Korean version of ICHD-IIIbeta. METHODS: Neurologists enrolled consecutive first-visit headache patients from February to March 2014. The classification of headache disorder was done by each investigator according to ICHD-IIIbeta based on the initial structured questionnaire, clinical evaluation, and neuroimaging studies, if needed. A consensus meeting dealt with the cases that were difficult to diagnose. The feasibility and usefulness of this version was assessed by the proportion of unclassified headache disorders using ICHD-IIIbeta compared to the previous version. RESULTS: A total of 207 patients were enrolled: the mean age was 41 years (16-87 years) and women constituted 63.3%. Primary headache disorders were diagnosed in 167 patients (80.7%): 82 migraines, 37 tension-type headaches, 3 cluster headaches, and 45 other primary headache disorders. Thirty-five patients (16.9%) had secondary headache disorders or painful cranial neuropathies/other facial pain and 5 patients (2.4%) could not be classified by ICHD-IIIbeta. The diagnoses differed as compared to the previous version in 32 patients (15.5%): 14.5% differed due to the mitigation of the previous strict criteria and 1% differed due to the introduction of a new diagnostic category. CONCLUSIONS: Classifications by ICHD-IIIbeta are possible in more than 97% of the first-visit headache patients and ICHD-IIIbeta has proved to be more useful than its previous version.
Classification* ; Cluster Headache ; Consensus ; Diagnosis ; Facial Pain ; Female ; Headache ; Headache Disorders* ; Headache Disorders, Primary ; Headache Disorders, Secondary ; Humans ; Migraine Disorders ; Neuroimaging ; Surveys and Questionnaires ; Research Personnel ; Tension-Type Headache

SUNCT syndrome is characterized by short-lasting, unilateral, neuralgiform headache attacks, with conjuntival injec-tion and tearing. Distinct from trigeminal neuralgia, cluster headache, or paroxysmal hemicrania, this rare syndrome is SUNCT syndrome is characterized by short-lasting, unilateral, neuralgiform headache attacks, with conjuntival injec-tion and tearing. Distinct from trigeminal neuralgia, cluster headache, or paroxysmal hemicrania, this rare syndrome is generally refractory to various medications. We report a 63-year-old man diagnosed with SUNCT syndrome, whose symptoms were relieved by verapamil. The therapeutic effects of verapamil on SUNCT syndrome remain to be verified by further experiences. (J Korean Neurol Assoc 19(4):407~409, 2001)
Cluster Headache ; Headache ; Humans ; Middle Aged ; Paroxysmal Hemicrania ; SUNCT Syndrome* ; Trigeminal Neuralgia ; Verapamil